Invention Grant
US07824669B2 In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants
有权
粒细胞 - 巨噬细胞集落刺激因子(GM-CSF)半胱氨酸突变蛋白及其聚乙二醇化变体体外刺激外周血祖细胞
- Patent Title: In vivo stimulation of peripheral blood progenitor cells by granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine muteins and their PEGylated variants
- Patent Title (中): 粒细胞 - 巨噬细胞集落刺激因子(GM-CSF)半胱氨酸突变蛋白及其聚乙二醇化变体体外刺激外周血祖细胞
-
Application No.: US12502839Application Date: 2009-07-14
-
Publication No.: US07824669B2Publication Date: 2010-11-02
- Inventor: George N. Cox, III , Daniel H. Doherty
- Applicant: George N. Cox, III , Daniel H. Doherty
- Applicant Address: US CO Boulder
- Assignee: Bolder Biotechnology, Inc.
- Current Assignee: Bolder Biotechnology, Inc.
- Current Assignee Address: US CO Boulder
- Agency: Sheridan Ross P.C.
- Main IPC: A61K45/00
- IPC: A61K45/00 ; C07K14/535 ; A61K38/19 ; C12N15/09 ; C12N15/19

Abstract:
The growth hormone supergene family comprises greater than 20 structurally related cytokines and growth factors. A general method is provided for creating site-specific, biologically active conjugates of these proteins. The method involves adding cysteine residues to non-essential regions of the proteins or substituting cysteine residues for non-essential amino acids in the proteins using site-directed mutagenesis and then covalently coupling a cysteine-reactive polymer or other type of cysteine-reactive moiety to the proteins via the added cysteine residue. Disclosed herein are preferred sites for adding cysteine residues or introducing cysteine substitutions into the proteins, and the proteins and protein derivatives produced thereby. Also disclosed are therapeutic methods for using the cysteine variants of the invention.
Public/Granted literature
- US20100029563A1 DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS, AND METHODS OF USE THEREOF Public/Granted day:2010-02-04
Information query